Literature DB >> 6283114

Interference among defective interfering particles of vesicular stomatitis virus.

D D Rao, A S Huang.   

Abstract

Three defective interfering (DI) particles of vesicular stomatitis virus (VSV), all derived from the same parental standard San Juan strain (Indiana serotype), were used in various combinations to infect cells together with the parental virus. The replication of their RNA genomes in the presence of other competing genomes was described by the hierarchical sequence: DI 0.52 particles greater than DI 0.45 particles less than or equal to DI-T particles greater than standard VSV. The advantage of one DI particle over another was not due simply to multiplicity effects nor to the irreversible occupation of limited cellular sites. Interference, however, did correlate with a change in the ratio of plus and minus RNA templates that accumulated intracellularly and with the presence of new sequences at the 3' end of the DI genomes. DI 0.52 particles contained significantly more nucleotides at the 3' end that were complementary to those at the 5' end of its RNA than did DI-T or DI 0.45 particles. The first 45 nucleotides at the 3' ends of all of the DI RNAs were identical. VSV and its DI particles can be separated into three classes, depending on their terminal RNA sequences. These sequences suggest two mechanisms, one based on the affinity of polymerase binding and the other on the affinity of N-protein binding, that may account for interference by DI particles against standard VSV and among DI particles themselves.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283114      PMCID: PMC256741     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Characterization of vesicular stomatitis virus nucleocapsids. I. Complementary 40 S RNA molecules in nucleocapsids.

Authors:  M Soria; S P Little; A S Huang
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

2.  Ribonucleic acid synthesis of vesicular stomatitis virus. VI. Correlation of defective particle RNA synthesis with standard RNA replication.

Authors:  E L Palma; S M Perlman; A S Huang
Journal:  J Mol Biol       Date:  1974-05-05       Impact factor: 5.469

Review 3.  Defective interfering viruses.

Authors:  A S Huang
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

4.  Absence of transcriptase activity or transcription-inhibiting ability in defective interfering particles of vesicular stomatitis virus.

Authors:  J Perrault; J J Holland
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

5.  Variability of vesicular stomatitis virus autointerference with different host cells and virus serotypes.

Authors:  J Perrault; J Holland
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

6.  Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles.

Authors:  A S Huang; E K Manders
Journal:  J Virol       Date:  1972-06       Impact factor: 5.103

7.  Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus.

Authors:  M E Reichmann; C R Pringle; E A Follett
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

8.  Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference.

Authors:  A S Huang; R R Wagner
Journal:  Virology       Date:  1966-10       Impact factor: 3.616

9.  Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties.

Authors:  A S Huang; J W Greenawalt; R R Wagner
Journal:  Virology       Date:  1966-10       Impact factor: 3.616

10.  Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase.

Authors:  P I Marcus; D L Engelhardt; J M Hunt; M J Sekellick
Journal:  Science       Date:  1971-11-05       Impact factor: 47.728

View more
  17 in total

1.  Defective Interference in the Killer System of Saccharomyces cerevisiae.

Authors:  S P Ridley; R B Wickner
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

2.  Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons.

Authors:  Ian R Wickersham; Heather A Sullivan; H Sebastian Seung
Journal:  Nat Protoc       Date:  2010-03-04       Impact factor: 13.491

3.  Nucleotide sequences that affect replicative and transcriptional efficiencies of Sendai virus deletion mutants.

Authors:  G G Re; D W Kingsbury
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Analysis of lymphocytic choriomeningitis virus gene expression in acutely and persistently infected mice.

Authors:  S J Francis; M K Singh; M B Oldstone; P J Southern
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

5.  Molecular analysis of viral RNAs in mice persistently infected with lymphocytic choriomeningitis virus.

Authors:  S J Francis; P J Southern
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

Review 6.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

7.  Structure and origin of a novel class of defective interfering particle of vesicular stomatitis virus.

Authors:  S T Nichol; P J O'Hara; J J Holland; J Perrault
Journal:  Nucleic Acids Res       Date:  1984-03-26       Impact factor: 16.971

8.  Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambisense rabies virus.

Authors:  S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

9.  Defective interfering virus particles modulate virulence.

Authors:  D R Cave; F M Hendrickson; A S Huang
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

Review 10.  Defective Interfering Particles of Negative-Strand RNA Viruses.

Authors:  Christopher M Ziegler; Jason W Botten
Journal:  Trends Microbiol       Date:  2020-03-26       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.